BlackRock Fund Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

BlackRock Fund Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$5.88M	Buy	565,440 +30,929	+6%	+$340K	﹤0.01%	2856
2016 Q3	$6.63M	Buy	534,511 +23,647	+5%	+$309K	﹤0.01%	2705
2016 Q2	$5.49M	Sell	510,864 -9,909	-2%	-$106K	﹤0.01%	2743
2016 Q1	$5.75M	Buy	520,773 +59,911	+13%	+$595K	﹤0.01%	2670
2015 Q4	$5.63M	Sell	460,862 -101,003	-18%	-$1.57M	﹤0.01%	2780
2015 Q3	$9.16M	Buy	561,865 +53,956	+11%	+$1.19M	﹤0.01%	2421
2015 Q2	$10.8M	Buy	507,909 +20,973	+4%	+$376K	﹤0.01%	2456
2015 Q1	$8.76M	Buy	486,936 +44,171	+10%	+$692K	﹤0.01%	2513
2014 Q4	$7.58M	Buy	+442,765	New	+$6.32M	﹤0.01%	2625

Other funds holding AVDL

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

BlackRock Fund Advisors's AVDL Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Avadel Pharmaceuticals (AVDL) stake by 5.8% in Q4 2016, buying an estimated $340K and bringing the position to 565,440 shares worth $5.88M. The position accounts for ﹤0.01% of the portfolio, ranked #2856.

BlackRock Fund Advisors first reported a position in AVDL in Q4 2014 and has held it in 9 quarters since. The position peaked at $10.8M in Q2 2015. 76 funds tracked by Wall St. Rank hold AVDL as of Q4 2016.

BlackRock Fund Advisors held 565,440 shares of Avadel Pharmaceuticals worth $5.88M as of Q4 2016.
BlackRock Fund Advisors bought 30,929 Avadel Pharmaceuticals shares in Q4 2016, an estimated $340K.
Avadel Pharmaceuticals made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2856 holding.
BlackRock Fund Advisors first reported a position in Avadel Pharmaceuticals in Q4 2014 and has held it in 9 quarters since.
BlackRock Fund Advisors's Avadel Pharmaceuticals position peaked at $10.8M in Q2 2015.
76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.